Eberechi Osuagwu
Family · Kansas City, KSNPI 1457741175
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 273 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Alkermes, Inc. at 24.5% of the total. 2025 is the largest year on record at $1,284, 2.2 times the $587 reported in 2021. Among family clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 273 payments — averaging $18.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$820
- Otsuka America Pharmaceutical, Inc.$616
- Neurocrine Biosciences, Inc.$601
- Teva Pharmaceuticals USA, Inc.$457
- Indivior Inc.$354
- plus $989 from 9 others
What the payments were for
- Food & beverage$5,083100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 67 | $1,247 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 53 | $820 |
| Otsuka America Pharmaceutical, Inc. | 34 | $616 |
| Neurocrine Biosciences, Inc. | 30 | $601 |
| Teva Pharmaceuticals USA, Inc. | 24 | $457 |
| Indivior Inc. | 18 | $354 |
| Johnson & Johnson | 11 | $315 |
| AbbVie | 11 | $199 |
| Vanda Pharmaceuticals Inc. | 9 | $169 |
| Lundbeck LLC | 7 | $119 |
| Axsome Therapeutics, Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $33 |
| Neuronetics, Inc. | 1 | $30 |
| Braeburn Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $16 |
How this compares
$5,083 in reported general payments places this provider in the 95th percentile of 1,579 family providers in Kansas.
Other family in Kansas City
- Zohra HussainiKansas City$329K
- Adam CaseKansas City$34K
- Kristina DelaneyKansas City$27K
- Amanda WilliamsKansas City$20K
- Mindy EldridgeKansas City$12K
- Liza RodriguezKansas City$11K
- Jhunne GalimbaKansas City$6K
- Graceann SandriKansas City$6K
- Jennifer ChesterOverland Park$327K
- Amanda CaldwellLeawood$203K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.